4.5 Article

Minimally invasive treatment for intracerebral hemorrhage

Journal

NEUROSURGICAL FOCUS
Volume 32, Issue 4, Pages -

Publisher

AMER ASSOC NEUROLOGICAL SURGEONS
DOI: 10.3171/2012.1.FOCUS11362

Keywords

intracerebral hemorrhage; sonothrombolysis; tissue plasminogen activator; intraventricular hemorrhage

Ask authors/readers for more resources

Spontaneous intracerebral hemorrhage is a serious public health problem and is fatal in 30%-50% of all occurrences. The role of open surgical management of supratentorial intracerebral hemorrhage is still unresolved. A recent consensus conference sponsored by the National Institutes of Health suggests that minimally invasive techniques to evacuate clots appear to be a promising area and warrant further investigation. In this paper the authors review past, current, and potential future methods of treating intraparenchymal hemorrhages with minimally invasive techniques and review new data regarding the role of stereotactically placed catheters and thrombolytics. (http://thejns.org/doi/abs/10.3171/2012.1.FOCUS11362)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Geriatrics & Gerontology

New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases

Johannes Boltze, Jaroslaw A. Aronowski, Jerome Badaut, Marion S. Buckwalter, Mateo Caleo, Michael Chopp, Kunjan R. Dave, Nadine Didwischus, Rick M. Dijkhuizen, Thorsten R. Doeppner, Jens P. Dreier, Karim Fouad, Mathias Gelderblom, Karen Gertz, Dominika Golubczyk, Barbara A. Gregson, Edith Hamel, Daniel F. Hanley, Wolfgang Haertig, Friedhelm C. Hummel, Maulana Ikhsan, Miroslaw Janowski, Jukka Jolkkonen, Saravanan S. Karuppagounder, Richard F. Keep, Inga K. Koerte, Zaal Kokaia, Peiying Li, Fudong Liu, Ignacio Lizasoain, Peter Ludewig, Gerlinde A. S. Metz, Axel Montagne, Andre Obenaus, Alex Palumbo, Monica Pearl, Miguel Perez-Pinzon, Anna M. Planas, Nikolaus Plesnila, Ami P. Raval, Maria A. Rueger, Lauren H. Sansing, Farida Sohrabji, Charlotte J. Stagg, R. Anne Stetler, Ann M. Stowe, Dandan Sun, Akihiko Taguchi, Mickael Tanter, Sabine U. Vay, Raghu Vemuganti, Denis Vivien, Piotr Walczak, Jian Wang, Ye Xiong, Marietta Zille

Summary: The past decade has witnessed significant advancements in both diagnosis and treatment of cerebrovascular diseases, with the introduction of thrombectomy in ischemic stroke and the identification of new therapeutic targets based on deeper understanding of pathomechanisms. Additionally, translational aspects are increasingly recognized in basic science studies, enhancing their predictive value for clinical application.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Immunology

Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage

Michael H. Askenase, Brittany A. Goods, Hannah E. Beatty, Arthur F. Steinschneider, Sofia E. Velazquez, Artem Osherov, Margaret J. Landreneau, Shaina L. Carroll, Tho B. Tran, Victor S. Avram, Riley S. Drake, G. James Gatter, Jordan A. Massey, Saravanan S. Karuppagounder, Rajiv R. Ratan, Charles C. Matouk, Kevin N. Sheth, Wendy C. Ziai, Adrian R. Parry-Jones, Issam A. Awad, Mario Zuccarello, Richard E. Thompson, Jesse Dawson, Daniel F. Hanley, J. Christopher Love, Alex K. Shalek, Lauren H. Sansing

Summary: By analyzing longitudinal transcriptional profiles in the hematomas of patients with ICH, it was found that the myeloid response to ICH displays a conserved progression from proinflammatory to proresolution states over time. These findings provide insights into the time course of immune responses in the human brain after injury and identify transcriptional programs associated with neurological recovery.

SCIENCE IMMUNOLOGY (2021)

Article Clinical Neurology

Intracerebral Hemorrhage Advances in Emergency Care

Carlos S. Kase, Daniel F. Hanley

NEUROLOGIC CLINICS (2021)

Article Medicine, Research & Experimental

Leukocyte dynamics after intracerebral hemorrhage in a living patient reveal rapid adaptations to tissue milieu

Brittany A. Goods, Michael H. Askenase, Erica Markarian, Hannah E. Beatty, Riley S. Drake, Ira Fleming, Jonathan H. DeLong, Naomi H. Philip, Charles C. Matouk, Issam A. Awad, Mario Zuccarello, Daniel F. Hanley, J. Christopher Love, Alex K. Shalek, Lauren H. Sansing

Summary: This study focused on intracerebral hemorrhage (ICH) in a patient, revealing the importance of inflammation in brain tissue injury and demonstrating dynamic changes in leukocyte responses over time using single-cell RNA-Seq. The findings suggest that sensitive methods such as scRNA-Seq could provide greater understanding of complex intracerebral events.

JCI INSIGHT (2021)

Article Immunology

CSF and serum inflammatory response and association with outcomes in spontaneous intracerebral hemorrhage with intraventricular extension: an analysis of the CLEAR-III Trial

Aaron M. Gusdon, Carol B. Thompson, Kendel Quirk, Yunis M. Mayasi, Radhika Avadhani, Issam A. Awad, Daniel F. Hanley, Wendy C. Ziai

Summary: The study found that in patients with ICH and IVH, treatment with alteplase compared to saline resulted in significantly enhanced inflammatory response in CSF leukocyte subtypes. Increased serum lymphocytes may be associated with better outcomes, while increased neutrophil-to-lymphocyte ratio (NLR) may be associated with worse outcomes.

JOURNAL OF NEUROINFLAMMATION (2021)

Editorial Material Neurosciences

What is the Price of the Potential for a Meaningful Recovery following Intracerebral Hemorrhage?

Lourdes R. Carhuapoma, Avni Kapadia, Henry A. Glick, Daniel F. Hanley

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Article Neurosciences

Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons Learned

Ali Mansour, Andrea Loggini, Faten El Ammar, Ronald Alvarado-Dyer, Sean Polster, Agnieszka Stadnik, Paramita Das, Peter C. Warnke, Bakhtiar Yamini, Christos Lazaridis, Christopher Kramer, W. Andrew Mould, Meghan Hildreth, Matthew Sharrock, Daniel F. Hanley, Fernando D. Goldenberg, Issam A. Awad

Summary: This study aimed to enhance procedure deployment rates and technical performance with minimally invasive surgery and thrombolysis for intracerebral hemorrhage (ICH) evacuation (MISTIE) in post-trial clinical practice. Results showed that AI-based measurements had excellent correlation with manual segmentation, and higher technical success rates were achieved in post-trial clinical practice compared to the MISTIE III trial.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Correction Immunology

Changes in motor function, cognition, and emotion-related behavior after right hemispheric intracerebral hemorrhage in various brain regions of mouse (vol 69, pg 568, 2018)

Wei Zhu, Yufeng Gao, Jieru Wan, Xi Lan, Xiaoning Han, Shanshan Zhu, Weidong Zang, Xuemei Chen, Wendy Ziai, Daniel F. Hanley, Scott J. Russo, Ricardo E. Jorge, Jian Wang

BRAIN BEHAVIOR AND IMMUNITY (2022)

Article Clinical Neurology

Intraventricular Hemorrhage Expansion in the CLEAR III Trial: A Post Hoc Exploratory Analysis

David J. Roh, Ifeyinwa S. Asonye, Fernanda Carvalho Poyraz, Jessica R. Magid-Bernstein, Evan F. Joiner, Radhika Avadhani, Issam Awad, Daniel F. Hanley, Wendy C. Ziai, Santosh B. Murthy

Summary: This study aimed to evaluate factors associated with intraventricular hemorrhage expansion and its impact on long-term outcomes. The authors found that acute hematoma characteristics, such as larger parenchymal volume, hematoma expansion, and thalamic intracerebral hemorrhage location, were associated with intraventricular hemorrhage expansion. Additionally, intraventricular hemorrhage expansion was associated with poor clinical outcomes. This study highlights the importance of optimizing hemostasis and preventing intraventricular hemorrhage expansion.

STROKE (2022)

Review Clinical Neurology

Mechanical thrombectomy with intra-arterial thrombolysis versus mechanical thrombectomy alone in patients with acute ischemic stroke: A systematic review and meta-analysis

Adnan Qureshi, Abdullah Lodhi, Iqra N. Akhtar, Xiaoyu Ma, Danish Kherani, Chun Shing Kwok, Daniel E. Ford, Daniel F. Hanley, Ameer E. Hassan, Thanh N. Nguyen, Alejandro M. Spiotta, Syed F. Zaidi

Summary: This systematic review found conflicting evidence on the benefit of intra-arterial thrombolysis (IAT) in patients with acute stroke undergoing mechanical thrombectomy (MT). Statistical analysis showed no significant difference in functional independence, mortality, or angiographic recanalization between IAT and MT alone. Furthermore, the study design and quality had a significant impact on the association between IAT and functional independence at 90 days.

INTERNATIONAL JOURNAL OF STROKE (2023)

Editorial Material Critical Care Medicine

Who Determines the Quality of Life of Survivors of Severe Traumatic Brain Injury?

Lourdes R. Carhuapoma, Radhika Avadhani, Daniel F. Hanley

NEUROCRITICAL CARE (2023)

Article Clinical Neurology

Minimally Invasive Surgery With Thrombolysis for Intracerebral Hemorrhage Evacuation

Abdulaziz T. Bako, Thomas Potter, Alan P. Pan, Jonika Tannous, Gavin Britz, Wendy C. Ziai, Issam Awad, Daniel Hanley, Farhaan S. Vahidy

Summary: The study examined the relationship between corticostriatal A beta-amyloid deposition and cognitive dysfunction in patients with Parkinson disease at risk for dementia. PET imaging and neuropsychological assessments were conducted on 40 PD patients, revealing a significant correlation between cortical PiB binding and global cognitive function.

NEUROLOGY (2023)

Letter Clinical Neurology

Reader Response: Functional Outcomes and Mortality in Patients With Intracerebral Hemorrhage After Intensive Medical and Surgical Support

Vishank A. Shah, Lourdes Carhuapoma, Daniel F. Hanley, Wendy C. Ziai

NEUROLOGY (2023)

Article Medicine, Research & Experimental

Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned

Daniel F. F. Hanley Jr, Gordon R. Bernard, Consuelo H. Wilkins, Harry P. Selker, Jamie P. Dwyer, J. Michael Dean, Daniel Kelly Benjamin Jr, Sarah E. Dunsmore, Salina P. Waddy, Kenneth L. L. Wiley Jr, Marisha E. Palm, W. Andrew Mould, Daniel F. Ford, Jeri S. Burr, Jacqueline Huvane, Karen Lane, Lori Poole, Terri L. Edwards, Nan Kennedy, Leslie R. Boone, Jasmine Bell, Emily Serdoz, Loretta M. Byrne, Paul A. Harris

Summary: New technologies and disruptions caused by COVID-19 have led to the expansion of decentralized clinical trials, which hold promise for increasing efficiency and reducing barriers. The Trial Innovation Network has provided recommendations for decentralized approaches and has consulted on numerous research proposals. While some elements of decentralized trials have worked well, others require further refinement and assessment. Efforts are needed to build trust and ensure access to remote technology for inclusive participation in decentralized clinical trials.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Review Medicine, Research & Experimental

The power of public-private partnership in medical technology innovation: Lessons from the development of FDA-cleared medical devices for assessment of concussion

Michael E. Singer, Dallas C. Hack, Daniel F. Hanley

Summary: This article explores the integration of the long development path of medical devices with the necessity for diagnostic capabilities for mild traumatic brain injury (mTBI/concussion), demonstrating the effective role of public-private partnerships (PPPs). Through PPP collaborations, multiple FDA clearances and product introductions have been achieved, meeting urgent military and public needs.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2022)

No Data Available